Your browser doesn't support javascript.
loading
TACI Isoforms Regulate Ligand Binding and Receptor Function.
Garcia-Carmona, Yolanda; Ting, Adrian T; Radigan, Lin; Athuluri Divakar, Sai Krishna; Chavez, Jose; Meffre, Eric; Cerutti, Andrea; Cunningham-Rundles, Charlotte.
Afiliação
  • Garcia-Carmona Y; Department of Clinical Immunology, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Ting AT; Department of Clinical Immunology, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Radigan L; Department of Clinical Immunology, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Athuluri Divakar SK; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Chavez J; Department of Clinical Immunology, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Meffre E; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, United States.
  • Cerutti A; Department of Clinical Immunology, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Cunningham-Rundles C; Catalan Institute for Research and Advance Studies (ICREA), Barcelona, Spain.
Front Immunol ; 9: 2125, 2018.
Article em En | MEDLINE | ID: mdl-30333819
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasmócitos / Fator Ativador de Células B / Membro 13 da Superfamília de Ligantes de Fatores de Necrose Tumoral / Proteína Transmembrana Ativadora e Interagente do CAML Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasmócitos / Fator Ativador de Células B / Membro 13 da Superfamília de Ligantes de Fatores de Necrose Tumoral / Proteína Transmembrana Ativadora e Interagente do CAML Idioma: En Ano de publicação: 2018 Tipo de documento: Article